Recognition: unknown
Triple-Phase Sequential Fusion Network for Hepatobiliary Phase Liver MRI Synthesis
Pith reviewed 2026-05-08 09:02 UTC · model grok-4.3
The pith
TriPF-Net synthesizes hepatobiliary phase liver MRI from earlier contrast phases even when some sequences are missing.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The Triple-Phase Sequential Fusion Network synthesizes hepatobiliary phase images by adaptively fusing features from available pre-HBP sequences using an Enhanced Region-Guided Encoder and Dynamic Feature Unification Module, trained with a Region-Guided Sequential Fusion Loss that enforces physiological consistency, and further conditioned on clinical variables, yielding MAE of 10.65 and 12.41, PSNR of 23.27 and 23.11, and SSIM of 0.76 and 0.78 on internal and external datasets respectively.
What carries the argument
The Triple-Phase Sequential Fusion Network with its Enhanced Region-Guided Encoder and Dynamic Feature Unification Module, which models contrast uptake across phases and unifies features dynamically.
Load-bearing premise
That image quality metrics such as MAE, PSNR, and SSIM combined with clinical variable inputs are enough to ensure the synthetic images match real ones for detecting and characterizing liver lesions.
What would settle it
A reader study comparing radiologist accuracy in hepatocellular carcinoma lesion detection and characterization on synthetic versus actual hepatobiliary phase images.
Figures
read the original abstract
Gadoxetate disodium-enhanced MRI is essential for the detection and characterization of hepatocellular carcinoma. However, acquisition of the hepatobiliary phase (HBP) requires a prolonged post-contrast delay, which reduces workflow efficiency and increases the risk of motion artifacts. In this study, we propose a Triple-Phase Sequential Fusion Network (TriPF-Net) to synthesize HBP images by leveraging the sequential information from pre-HBP sequences: while T1-weighted imaging serves as the indispensable baseline, the model adaptively integrates arterial-phase (AP) and venous-phase (VP) features when available. By modeling the tissue-specific contrast uptake and excretion dynamics across these three phases, TriPF-Net ensures robust HBP synthesis even under the stochastic absence of one or both dynamic contrast-enhanced sequences. The framework comprises an Enhanced Region-Guided Encoder and a Dynamic Feature Unification Module, optimized with a Region-Guided Sequential Fusion Loss to maintain physiological consistency. In addition, clinical variables, including age, sex, total bilirubin, and albumin, are incorporated to enhance physiological consistency. Compared with conventional methods, TriPF-Net achieved superior performance on datasets from two centers. On the internal dataset, the model achieved an MAE of 10.65, a PSNR of 23.27, and an SSIM of 0.76. On the external validation dataset, the corresponding values were 12.41, 23.11, and 0.78, respectively. This flexible solution enhances clinical workflow and lesion depiction, potentially eliminating the need for delayed HBP acquisition in HCC imaging.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript proposes the Triple-Phase Sequential Fusion Network (TriPF-Net) to synthesize hepatobiliary phase (HBP) liver MRI images from pre-HBP sequences (T1-weighted imaging as baseline, plus arterial-phase and venous-phase when available). The architecture includes an Enhanced Region-Guided Encoder and Dynamic Feature Unification Module, trained with a Region-Guided Sequential Fusion Loss and conditioned on clinical variables (age, sex, total bilirubin, albumin) to model contrast uptake/excretion dynamics. The method claims robustness to stochastic absence of one or both dynamic phases and reports superior quantitative performance versus conventional methods on internal (MAE 10.65, PSNR 23.27, SSIM 0.76) and external (MAE 12.41, PSNR 23.11, SSIM 0.78) multi-center datasets, with potential to eliminate delayed HBP acquisition for HCC imaging.
Significance. If the synthesized images prove diagnostically equivalent, the work could meaningfully improve clinical workflow by shortening scan times and reducing motion artifacts in gadoxetate-enhanced liver MRI. Strengths include explicit handling of missing phases, multi-center external validation, and incorporation of clinical scalars alongside region-guided mechanisms. These elements address practical deployment challenges, though the overall significance remains constrained by reliance on pixel-level metrics alone.
major comments (3)
- [Abstract] Abstract and Results: The central claim that the method 'enhances ... lesion depiction' and 'potentially eliminat[es] the need for delayed HBP acquisition' is not supported by any lesion-level diagnostic validation. No reader studies, LI-RADS concordance rates, or lesion characterization metrics (sensitivity/specificity for HCC) comparing real versus synthetic HBP images are reported; only MAE/PSNR/SSIM are provided.
- [Results] Results section: The statement of 'superior performance ... compared with conventional methods' lacks any description or citation of the specific baseline methods, their implementations, or hyperparameter settings, preventing assessment of whether the reported metric gains (e.g., MAE 10.65 vs. baselines on internal data) are meaningful.
- [Methods] Methods (Region-Guided Sequential Fusion Loss): The loss is presented as ensuring 'physiological consistency,' yet no ablation studies, comparison against physiological ground-truth parameters, or correlation with clinical variables beyond the reported image metrics are shown to substantiate this property.
minor comments (2)
- [Abstract] The abstract refers to 'conventional methods' without naming them; this detail should be added for clarity.
- Ensure first-use definitions for all acronyms (TriPF-Net, HBP, AP, VP, MAE, PSNR, SSIM) and consistent notation for clinical variables throughout the text and figures.
Simulated Author's Rebuttal
We thank the referee for the constructive and detailed comments. We address each major point below and have revised the manuscript to improve clarity, transparency, and accuracy of claims.
read point-by-point responses
-
Referee: [Abstract] Abstract and Results: The central claim that the method 'enhances ... lesion depiction' and 'potentially eliminat[es] the need for delayed HBP acquisition' is not supported by any lesion-level diagnostic validation. No reader studies, LI-RADS concordance rates, or lesion characterization metrics (sensitivity/specificity for HCC) comparing real versus synthetic HBP images are reported; only MAE/PSNR/SSIM are provided.
Authors: We agree that the original claims regarding lesion depiction and elimination of HBP acquisition rest on image-level metrics rather than direct diagnostic validation. The reported MAE, PSNR, and SSIM improvements indicate higher fidelity to real HBP images, which we hypothesized could translate to better lesion visibility, but we acknowledge this inference requires clinical confirmation. In the revised manuscript, we have moderated the abstract and discussion language to state that the approach shows promise for workflow improvement based on synthesis quality, while explicitly noting the absence of reader studies or LI-RADS assessments and outlining them as future work. revision: yes
-
Referee: [Results] Results section: The statement of 'superior performance ... compared with conventional methods' lacks any description or citation of the specific baseline methods, their implementations, or hyperparameter settings, preventing assessment of whether the reported metric gains (e.g., MAE 10.65 vs. baselines on internal data) are meaningful.
Authors: We thank the referee for highlighting this omission. The revised manuscript now includes an expanded Methods subsection that describes each baseline method with original citations, our re-implementation details, and the specific hyperparameter settings used during comparison. This addition enables readers to assess the reported gains (e.g., MAE 10.65 on internal data) in proper context. revision: yes
-
Referee: [Methods] Methods (Region-Guided Sequential Fusion Loss): The loss is presented as ensuring 'physiological consistency,' yet no ablation studies, comparison against physiological ground-truth parameters, or correlation with clinical variables beyond the reported image metrics are shown to substantiate this property.
Authors: The Region-Guided Sequential Fusion Loss was designed with terms that enforce phase-consistent contrast behavior aligned with known hepatobiliary uptake/excretion patterns, and clinical variables were included to modulate these dynamics. We recognize that direct empirical support via ablations or explicit correlations was not provided. The revised manuscript adds ablation experiments that isolate the contribution of the region-guided and sequential fusion components, together with supplementary correlation analyses between synthesized liver intensities and clinical scalars such as bilirubin and albumin levels. revision: yes
Circularity Check
No significant circularity; empirical ML results on held-out data
full rationale
The paper proposes TriPF-Net, a neural network for HBP MRI synthesis trained on multi-phase data and evaluated via standard image metrics on internal and external held-out datasets. The architecture (Enhanced Region-Guided Encoder, Dynamic Feature Unification Module, Region-Guided Sequential Fusion Loss) and clinical variable conditioning are design choices whose effectiveness is measured by data-driven performance rather than any equation or prediction that reduces to its own inputs by construction. No self-definitional steps, fitted parameters renamed as predictions, or load-bearing self-citations appear in the derivation chain. External validation supplies statistical independence, making the central empirical claims self-contained.
Axiom & Free-Parameter Ledger
Reference graph
Works this paper leans on
-
[1]
F. Bray, M. Laversanne, H. Sung,et al., Global cancer statistics 2022: Globocan estimates of incidence and mor- tality worldwide for 36 cancers in 185 countries, CA: a cancer journal for clinicians 74 (3) (2024) 229–263
2022
-
[2]
J. Han, B. Wang, W. Liu,et al., Declining disease burden of hcc in the u nited s tates, 1992–2017: A population- based analysis, Hepatology 76 (3) (2022) 576–588
1992
-
[3]
Kamaya, D
A. Kamaya, D. T. Fetzer, J. H. Seow,et al., Li-rads us surveillance version 2024 for surveillance of hepatocellu- lar carcinoma: an update to the american college of radi- ology us li-rads, Radiology 313 (3) (2024) e240169
2024
-
[4]
M. Yan, X. Zhang, B. Zhang,et al., Deep learning nomo- gram based on gd-eob-dtpa mri for predicting early re- currence in hepatocellular carcinoma after hepatectomy, European Radiology 33 (7) (2023) 4949–4961
2023
-
[5]
Jiang, H
H. Jiang, H. Wei, T. Yang,et al., Vict2 trait: prognostic al- ternative to peritumoral hepatobiliary phase hypointensity in hcc, Radiology 307 (2) (2023) e221835
2023
-
[6]
Y . Yu, Y . Fan, X. Wang,et al., Gd-eob-dtpa-enhanced mri radiomics to predict vessels encapsulating tumor clusters (vetc) and patient prognosis in hepatocellular carcinoma, European Radiology 32 (2) (2022) 959–970
2022
-
[7]
J. Zhao, D. Li, Z. Kassam,et al., Tripartite-gan: Synthe- sizing liver contrast-enhanced mri to improve tumor de- tection, Medical image analysis 63 (2020) 101667
2020
-
[8]
Haubold, G
J. Haubold, G. Jost, J. M. Theysohn,et al., Contrast agent dose reduction in mri utilizing a generative adversarial network in an exploratory animal study, Investigative Ra- diology 58 (6) (2023) 396–404
2023
-
[9]
R. Azad, M. Dehghanmanshadi, N. Khosravi,et al., Addressing missing modality challenges in mri images: A comprehensive review, Computational Visual Media 11 (2) (2025) 241–268
2025
-
[10]
Yoshimitsu, A
K. Yoshimitsu, A. Nishie, Y . Takayama,et al., The washout of hepatocellular carcinoma at portal venous phase vs. equilibrium phase: Radiological and clinico- pathological implication, Cancers 17 (19) (2025) 3195
2025
-
[11]
Wang, X.-D
C. Wang, X.-D. Yuan, N. Wu,et al., Optimization of hepa- tobiliary phase imaging in gadoxetic acid-enhanced mag- netic resonance imaging: a narrative review, Quantitative Imaging in Medicine and Surgery 13 (3) (2023) 1972
2023
-
[12]
Taouli, A
B. Taouli, A. Ba-Ssalamah, J. Chapiro,et al., Consensus report from the 10th global forum for liver magnetic reso- nance imaging: developments in hcc management, Euro- pean Radiology 33 (12) (2023) 9152–9166
2023
-
[13]
Caparroz, A
C. Caparroz, A. Forner, J. Rimola,et al., Portal hyper- tension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid mr, Radiology and Oncology 56 (3) (2022) 292
2022
-
[14]
S. Li, B. Liu, F. Deng,et al., Image synthesis of hep- atobiliary phase using contrast-enhanced mri and diffu- sion model, in: 2024 IEEE International Symposium on Biomedical Imaging (ISBI), IEEE, 2024, pp. 1–5
2024
-
[15]
J. Liu, Y . Li, N. Shi,et al., Multi-phase liver-specific dce- mri translation via a registration-guided gan, in: Interna- tional workshop on simulation and synthesis in medical imaging, Springer, 2023, pp. 21–31
2023
-
[16]
S. A. Abosabie, S. A. Abosabie, W. Dai,et al., Deep learning-based generation of synthetic multiphasic mri in hepatocellular carcinoma and cirrhosis, JHEP Reports (2026) 101813
2026
- [17]
-
[18]
Y . Shi, W. Xia, C. Niu,et al., Privacy-preserving latent diffusion-based synthetic medical image generation, IEEE Transactions on Medical Imaging 45 (3) (2026) 1140– 1151.doi:10.1109/TMI.2025.3618511
-
[20]
W. Yuan, J. Wei, J. Wang,et al., Unified generative ad- versarial networks for multimodal segmentation from un- paired 3d medical images, Medical Image Analysis 64 (2020) 101731.doi:https://doi.org/10.1016/j. media.2020.101731
work page doi:10.1016/j 2020
-
[21]
C. Gao, B. Killeen, Y . Hu,et al., Synthetic data accelerates the development of generalizable learning- based algorithms for x-ray image analysis, Nature Ma- chine Intelligence 5 (2023) 294–308.doi:10.1038/ s42256-023-00629-1
2023
-
[22]
A. Alqutayfi, S. Al-Azani, Mri cross-modal synthesis: A comparative study of generative models for t1-to-t2 recon- struction, ArXiv abs/2602.07068 (2026)
-
[23]
H. Li, J. C. Paetzold, A. Sekuboyina,et al., Diamondgan: Unified multi-modal generative adversarial networks for mri sequences synthesis, in: Medical Image Comput- ing and Computer Assisted Intervention – MICCAI 2019, Springer International Publishing, Cham, 2019, pp. 795– 803
2019
-
[24]
T. Zhou, H. Fu, G. Chen,et al., Hi-net: Hybrid-fusion net- work for multi-modal mr image synthesis, IEEE Trans- actions on Medical Imaging 39 (9) (2020) 2772–2781. doi:10.1109/TMI.2020.2975344
-
[25]
X. Jia, B. Li, J. Ma,et al., Multi-modal medical im- age synthesis via dual-branch wavelet encoding and de- formable feature interaction, Artificial Intelligence in Medicine 171 (2026) 103287.doi:https://doi.org/ 10.1016/j.artmed.2025.103287
-
[26]
Zhang, C
Y . Zhang, C. Peng, Q. W.et al., Unified multi-modal image synthesis for missing modality imputation, IEEE Transactions on Medical Imaging 44 (2023) 4–18. 11
2023
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.